There’s no doubt that the Apple Watch genuinely makes people’s lives better, which is one of the reasons why it’s become one of the most popular wearables on the market today (or saves them for that matter). You can believe whatever you want to about Apple and its products, but the numerous success stories revolving around the Apple Watch deserve some attention.
A new application for the Apple Watch has been approved by the Food and Drug Administration (FDA) to track Parkinson’s disease patients. Reuters reports that Rune Labs, a San Francisco-based health business, has been granted permission to run a specific software on the watch to monitor symptoms of Parkinson’s disease.
The software in question is able to recognize and keep track of common signs of the disease, such as tremors, movement that is involuntary or slow, rigidity, and poor balance, among other symptoms. Back in 2018, Apple included software that could detect a heavy fall with its Watch Series 4; the company later made this software available to the public as part of its open-source ResearchKit.
Thus, watchOS apps and solutions for tracking various conditions with symptoms involving irregular movement could be built using the Movement Disorder API by developers.
Rune Lab’s solution is the first commercially available wearable to track such illnesses. Patients’ conditions are to be tracked over time, and doctors and medical professionals will have access to this information.
The software, of course, has its limitations, but it is designed to supplement the traditional full-blown in-person medical examination. The Apple Watch’s AFib History feature was approved by the FDA earlier this month, allowing users over the age of 22 to use the watch to monitor their heart condition. This isn’t the first Apple Watch feature to receive FDA approval.